For people with hospitalizations due to influenza, oseltamivir treatment was associated with a lower mortality risk, earlier discharge, and lower readmission rates in a large retrospective study published in JAMA Network Open. Researchers analyzed 11,073 hospitalized adults with seasonal influenza across 30 Canadian hospitals from 2015 through 2023 and found when oseltamivir treatment was initiated in the hospital on day 0 or day 1, patients experienced significantly improved outcomes compared to those who had supportive …
Read More